Homeward
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward announced $120M in Series D financing on October 1, 2026. Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Round details
The financing includes backing from Saluda Grade, Continental General Insurance Company, Citi Ventures, Magnetar, Harmony Partners, Norwest, Adams Street Partners, LiveOak Ventures. The company did not publish a valuation with the announcement.
- Round: Series D
- Capital announced: $120M
- Headquarters: Austin, TX
How the company plans to use the capital
Homeward said the new capital, including the Series D equity and the debt facilities, will expand its cash offer and bridge financing solutions, enhance the technology behind its integrated home buying and selling platform, and accelerate growth across the 48 contiguous states. The company said the $330 million asset-backed debt facility will be used to fund more home transactions.
Why this matters for GTM teams
The financing shows investor backing for cash offer and bridge financing tools that, according to the company, aim to give buyers and sellers greater certainty during home transactions.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Homeward Series D announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


